# Stryker (SYK) — Analyst Forecast

SYK · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/syk/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 24 | 6 | 0 | 30 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $298.00 | $360.15 | $420.00 | 13 |

Last price $293.23 (as of Oct 16, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 12, 2026 | BTIG | Maintained | Buy | $316.00 |
| Oct 7, 2026 | Truist Securities | Maintained | Hold | $310.00 |
| Oct 7, 2026 | Barclays | Initiated Coverage | Overweight | $375.00 |
| Sep 30, 2026 | Stifel | Maintained | Buy | $330.00 |
| Sep 22, 2026 | TD Cowen | Maintained | Hold | $298.00 |
| Sep 18, 2026 | Canaccord Genuity | Maintained | Buy | $385.00 |
| Sep 10, 2026 | Citigroup | Maintained | Buy | $360.00 |
| Sep 9, 2026 | Wells Fargo | Maintained | Overweight | $348.00 |
| Aug 13, 2026 | Wolfe Research | Downgraded | Outperform → Peer Perform | — |
| Aug 3, 2026 | Citizens | Maintained | Market Outperform | $400.00 |
| Jul 31, 2026 | BTIG | Maintained | Buy | $358.00 |
| Jul 31, 2026 | Truist Securities | Maintained | Hold | $340.00 |
| Jul 31, 2026 | Piper Sandler | Maintained | Overweight | $390.00 |
| Jul 31, 2026 | JP Morgan | Maintained | Overweight | $350.00 |
| Jul 31, 2026 | RBC Capital | Maintained | Outperform | $420.00 |
| Jul 28, 2026 | UBS | Initiated Coverage | Neutral → Buy | $400.00 |
| Jul 9, 2026 | BMO Capital | Initiated Coverage | Market Perform → Outperform | $369.00 |
| Jul 6, 2026 | Evercore ISI Group | Maintained | Outperform | $350.00 |
| Jun 5, 2026 | Leerink Partners | Maintained | Outperform | $407.00 |
| May 4, 2026 | Barclays | Maintained | Overweight | $394.00 |

## Frequently Asked Questions

### What is the price target for SYK stock?

The average 12-month analyst price target for Stryker (SYK) is $360.15, with a high estimate of $420.00 and a low of $298.00, across 13 analysts.

### Is SYK a buy, sell, or hold?

Analysts covering Stryker currently average a Buy rating: 24 buy, 6 hold and 0 sell, from 30 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for SYK?

The average price target of $360.15 implies 22.82% upside from the last price of $293.23.

### What is the latest analyst rating on SYK?

On Oct 12, 2026, BTIG maintained Stryker at Buy with a price target of $316.00.

## Similar Stocks

- [CAH](https://www.lighthorse.io/tickers/cah) — Cardinal Health, Inc. Common Stock
- [DVA](https://www.lighthorse.io/tickers/dva) — DaVita Inc. Common Stock
- [COR](https://www.lighthorse.io/tickers/cor) — Cencora, Inc. Common Stock
- [ZBH](https://www.lighthorse.io/tickers/zbh) — Zimmer Biomet Holdings, Inc. Common Stock
- [MDT](https://www.lighthorse.io/tickers/mdt) — Medtronic plc. Ordinary Shares
- [ISRG](https://www.lighthorse.io/tickers/isrg) — Intuitive Surgical, Inc. - Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).